Sort
48,018 grants matching “immunotherapy”
Shared Resource: Proteomics & Metabolomics
$374,777Philip Robert Gafken · Fred Hutchinson Cancer Center · P30 · FY2022 · CA
Shared Resource: Proteomics & Metabolomics
$374,776Philip Robert Gafken · Fred Hutchinson Cancer Center · P30 · FY2023 · CA
Remotely activated biomaterial scaffolds for flexibly directing the recruitment and differentiation of bone progenitor cells
$374,765Geoffrey D Bothun · University Of Rhode Island · · FY2016 · ENG
Project 3: Modulation of the head and neck tumor immune microenvironment by targeting the TAM family of receptors
$374,756Deric L Wheeler · University Of Wisconsin-Madison · P50 · FY2022 · CA
Mechanistic Analysis of Anti-IgE Therapy of Asthma
$374,713University Of Texas Sw Med Ctr/Dallas · R01 · FY2001 · AI
Effects of PGE2 on Reconstitution of Hematopoiesis and Immunity after UCBT
$374,707Vassiliki A Boussiotis · Beth Israel Deaconess Medical Center · R01 · FY2015 · CA
Transgenesis and Xenotransplantation
$374,700Jorge A. Piedrahita · North Carolina State University Raleigh · R01 · FY2011 · HL
Targeted inhibition in stromal TGFβ activity in pancreatic cancer
$374,691Rolf A Brekken · Ut Southwestern Medical Center · R01 · FY2020 · CA
Novel Biological Activities of Anti-Viral Antibody
$374,660University Of California Irvine · R01 · FY2003 · AI
Optimal Pairing of Chemotherapy with Immunotherapy for Pancreatic Cancer
$374,645Peter A Cohen · Mayo Clinic Rochester · P50 · FY2014 · CA
Statistical Methods for RNA-seq Data Analysis
$374,633Wei Sun · Fred Hutchinson Cancer Research Center · R01 · FY2019 · GM
INTRATHECAL 131 I 3F8 FOR LEPTOMENINGEAL MALIGNANCIES
$374,625Sloan-Kettering Institute For Cancer Res · R21 · FY2001 · CA
INTRATHECAL 131 I 3F8 FOR LEPTOMENINGEAL MALIGNANCIES
$374,625Sloan-Kettering Institute For Cancer Res · R21 · FY2000 · CA
DENDRITIC CELL THERAPY OF CHRONIC MYELOGENOUS LEUKEMIA
$374,591Mayo Clinic Coll Of Medicine, Rochester · R01 · FY2001 · CA
Targeting Tumor Metabolism as a Means of Enhancing Immunotherapy
$374,578Jonathan D Powell · Johns Hopkins University · R01 · FY2020 · CA
Role of YAP in Treg Function and YAP Targeting for Cancer Immunotherapy
$374,578Drew M. Pardoll · Johns Hopkins University · R01 · FY2021 · CA
A PLATFORM TECHNOLOGY TO GENETICALLY REPROGRAM CANCER CELLS FOR ENHANCED IMMUNOTHERAPY
$374,578Stephany Yi Tzeng · Johns Hopkins University · R37 · FY2021 · CA
A PLATFORM TECHNOLOGY TO GENETICALLY REPROGRAM CANCER CELLS FOR ENHANCED IMMUNOTHERAPY
$374,578Stephany Yi Tzeng · Johns Hopkins University · R37 · FY2022 · CA
Correlates of antitumor immunity in colorectal cancers and anti PD1 therapy
$374,578Franck Housseau · Johns Hopkins University · R01 · FY2020 · CA
Correlates of antitumor immunity in colorectal cancers and anti PD1 therapy
$374,578Franck Housseau · Johns Hopkins University · R01 · FY2018 · CA
Targeting Tumor Metabolism as a Means of Enhancing Immunotherapy
$374,578Robert David Leone · Johns Hopkins University · R01 · FY2021 · CA
A PLATFORM TECHNOLOGY TO GENETICALLY REPROGRAM CANCER CELLS FOR ENHANCED IMMUNOTHERAPY
$374,578Stephany Yi Tzeng · Johns Hopkins University · R37 · FY2020 · CA
Generating a Systemic Immune Response Using Localized Delivery of Chemotherapy in Brain Tumors
$374,578Michael Lim · Johns Hopkins University · R01 · FY2019 · CA
Role of intratumoral high endothelial venules in tumor immunity
$374,578Masanobu Komatsu · Johns Hopkins University · R01 · FY2022 · CA
Role of intratumoral high endothelial venules in tumor immunity
$374,578Masanobu Komatsu · Johns Hopkins University · R01 · FY2025 · CA